ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of the Safety and Effectiveness of LGH447 and BYL719 in Patients With Relapsed and Refractory Multiple Myeloma

Novartis Pharmaceuticals · 2014
ClinicalTrials.gov · Datasets · License: Public Domain · 2014
Open Source ↗
multiple-myeloma
relapsed and refractory multiple myeloma, multiple myeloma,, relapsed and refractory,, lgh447,, pan-pim inhibitor,, pim kinase,, byl719,, pi3k inhibitor, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 851980
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.